Medical Device Network on MSN
StimLabs launches Allacor P for acute and chronic wound care
StimLabs has announced the launch of Allacor P, a human umbilical cord device designed for acute and chronic wound management ...
StimLabs®, a leading regenerative medicine company, announces the launch of Allacor P, the first medical device derived from human umbilical cord extracellular matrix (ECM). Allacor P was awarded an A ...
Medical Device Network on MSN
TYBR Health reports first clinical use of tissue protector in US
TYBR Health has announced the first US clinical use of the collagen-based tissue protector, B3 GEL System, aimed at ...
PITTSBURGH--(BUSINESS WIRE)--ECM Therapeutics, a clinical stage regenerative medicine company pioneering the development of Extracellular Matrix-based therapeutics for the treatment of unmet medical ...
TYBR Health, a regenerative medicine and medical device company focused on improving post-surgical soft-tissue healing, today ...
Scientists have developed a synthetic extracellular matrix (ECM) that can support the growth of a mini endometrium in a dish for at least two weeks. The endometrium -- the mucosal lining of the uterus ...
A new study, led by Prof. Liu from the department of pharmacy, University of Electronic Science and Technology of China, discovered that the extracellular cell matrix (ECM) could induce the drug ...
Figure 1. (click to enlarge) Fibroblasts (blue DAPI stain) cultured on bead-like sphere structures produce embryonic ECM. Tissue engineering and regenerative medicine use various scaffolds, living ...
In a study published in Cell Stem Cell, researchers led by Profs. DAI Jianwu and ZHAO Yannan from the Institute of Genetics and Developmental Biology of the Chinese Academy of Sciences have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback